SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R) (flunisolide HFA, 80 mcg) Inhalation Aerosol